Cargando…
miR-133a function in the pathogenesis of dedifferentiated liposarcoma
BACKGROUND: Sarcomas are malignant heterogeneous tumors of mesenchymal derivation. Dedifferentiated liposarcoma (DDLPS) is aggressive with recurrence in 80% and metastasis in 20% of patients. We previously found that miR-133a was significantly underexpressed in liposarcoma tissues. As this miRNA has...
Autores principales: | Yu, Peter Y., Lopez, Gonzalo, Braggio, Danielle, Koller, David, Bill, Kate Lynn J., Prudner, Bethany C., Zewdu, Abbie, Chen, James L., Iwenofu, O. Hans, Lev, Dina, Strohecker, Anne M., Fenger, Joelle M., Pollock, Raphael E., Guttridge, Denis C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019219/ https://www.ncbi.nlm.nih.gov/pubmed/29983640 http://dx.doi.org/10.1186/s12935-018-0583-2 |
Ejemplares similares
-
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates
por: Lopez, Gonzalo, et al.
Publicado: (2017) -
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Lopez, Gonzalo, et al.
Publicado: (2015) -
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma
por: Bill, Kate Lynn J., et al.
Publicado: (2015) -
Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis
por: Zewdu, A, et al.
Publicado: (2016) -
Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous dedifferentiation
por: Nguyen, Vinh N., et al.
Publicado: (2015)